Workflow
Putin greenlights Citigroup sale after months of state-imposed restrictions
Invezz· 2025-11-12 22:32
Citigroup has finally secured Russian state approval to sell its local banking operations, nearly a year and a half after announcing plans to leave the market. On Wednesday, a presidential order signe... ...
从“世界橱窗”到“国民卖场”:中国健康消费正在换挡提速
中国新闻网· 2025-11-12 22:31
在刚刚落幕的进博会上,京东健康频频现身各大药企展台,与二十余家跨国药企、营养保健及医疗器械品牌达成深度合作,覆盖慢病管理、女性健康、肿瘤 防治、营养保健等全健康场景。 这不仅是规模扩张,更是模式升级——平台与药企的关系,正从单纯的"卖药"走向"健康生态共建"。 这一变化在双11期间得到印证:平台数据显示,京东11.11全周期,京东健康旗下医药、营养保健、医疗器械三大板块全面开花,超7000个品牌成交额同比 翻倍。 超级医药供应链:打通创新药落地的"最后一公里" 线上渠道已成为跨国药企创新药进入中国市场的首选阵地。仅今年上半年,就有30多款创新药在京东健康完成全网首发。 新药能否快速上架,不只是简单销售商品,更考验平台在供应链、医疗服务和数字化管理上的综合能力。 以京东健康与信达生物合作的创新药信尔美(通用名:玛仕度肽注射液)为例,这款全球首个获批的GCG/GLP-1双受体激动剂,从获批到在京东健康全网 首发仅用7天。 这款需要全程保持2-8℃恒温环境下运输的生物制剂,对冷链物流提出了极高要求。任何温度波动都可能影响药效,要求供应链必须具备精准的温控能力和 快速的响应机制。 支撑这一需求落地的,是京东健康覆盖全 ...
DATA Communications Management Corp. 2025 Q3 - Results - Earnings Call Presentation (TSX:DCM:CA) 2025-11-12
Seeking Alpha· 2025-11-12 22:31
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...
CELH Stock Down 27% After Q3 Results: Should You Buy the Dip?
ZACKS· 2025-11-12 22:31
Key Takeaways CELH shares fell about 27% after Q3 despite net sales rising 173% to $725.1 million. Management warned Q4 will be "noisy" as Alani Nu moves to PepsiCo's DSD and Rockstar integration continues. CELH's partnership with PepsiCo continues to drive retail reach and strengthen its U.S. energy drink share. Celsius Holdings, Inc. ((CELH) shares have fallen about 27% since the company reported its third-quarter fiscal 2025 results on Nov. 6. Despite solid quarterly results, investors reacted cautiously ...
Will AWS' Growing Capital Spending Boost or Burden Amazon Stock?
ZACKS· 2025-11-12 22:31
Key Takeaways Amazon plans over $75B in 2024 capital spending, mostly for AWS AI and data center expansion.AWS posted $27.5B in Q3 revenues, up 19% year over year, with operating margin climbing to 38%.Management expects Q4 sales of $181.5-$188.5B and operating income between $16B and $20B.Amazon's (AMZN) aggressive capital expenditure plans for its Amazon Web Services (“AWS”) division signal confidence in the cloud computing market's growth trajectory, positioning the stock as a compelling investment oppor ...
Innoviz Technologies Ltd. 2025 Q3 - Results - Earnings Call Presentation (NASDAQ:INVZ) 2025-11-12
Seeking Alpha· 2025-11-12 22:31
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...
Opus Genetics, Inc. (IRD) Reports Q3 Loss, Beats Revenue Estimates
ZACKS· 2025-11-12 22:31
Opus Genetics, Inc. (IRD) came out with a quarterly loss of $0.12 per share versus the Zacks Consensus Estimate of a loss of $0.14. This compares to a loss of $0.29 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +14.29%. A quarter ago, it was expected that this company would post a loss of $0.25 per share when it actually produced a loss of $0.12, delivering a surprise of +52%.Over the last four quarters, the company has surp ...
Humacyte, Inc. (HUMA) Reports Q3 Loss, Misses Revenue Estimates
ZACKS· 2025-11-12 22:31
Humacyte, Inc. (HUMA) came out with a quarterly loss of $0.14 per share versus the Zacks Consensus Estimate of a loss of $0.17. This compares to a loss of $0.33 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +17.65%. A quarter ago, it was expected that this company would post a loss of $0.15 per share when it actually produced a loss of $0.24, delivering a surprise of -60%.Over the last four quarters, the company has surpasse ...
EnWave inks royalty-bearing license deal with New Zealand's Shinyway International
Proactiveinvestors NA· 2025-11-12 22:31
About this content About Sean Mason Sean Mason is a Senior Journalist at Proactive, having researched and written about Canadian and US equities for 20 years. Sean graduated from the University of Toronto with a BA in history and economics and has also passed the Canadian Securities Course. He previously worked at Investors Digest of Canada, Stockhouse, and SmallCapPower.com. Read more About the publisher Proactive financial news and online broadcast teams provide fast, accessible, informative and action ...
Full Employment to Be a Challenge for Years, BlackRock's Rieder Says
Youtube· 2025-11-12 22:31
Have we got a labor market problem. I do, I do. And by the way, I don't think it's a cyclical phenomenon.I think there is, or at least I think we have a productivity revolution that is pretty extraordinary and people point to is an exclusive driver of that. If you look across what companies are doing, including second quarter earnings, their quarter earnings give you a dynamic around around how you think about logistics, freight management, predictive maintenance, customer procurement. Companies are doing m ...